Surgipro SP-623 SURGIPRO* 2-0 BLU 75CM SC2 X36 SP-623 Recall
Surgipro SP-623 SURGIPRO* 2-0 BLU 75CM SC2 X36 SP-623
FDA recall Class II
Ongoing
FDA lists this Class II recall for Surgipro SP-623 SURGIPRO* 2-0 BLU 75CM SC2 X36 SP-623. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2921-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Jun 24, 2026
- FDA report date
- Aug 19, 2026
- Quantity in commerce
- 135,875 total
- Distribution
- See key details
- FDA cause
- Equipment maintenance
What is being recalled?
Surgipro SP-623 SURGIPRO* 2-0 BLU 75CM SC2 X36 SP-623
Affected model & UDI checker
Search the exact identifiers published for Z-2921-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | Surgipro SP-623 SURGIPRO* 2-0 BLU 75CM SC2 X36 SP-623 | Check source notice | 20884521037073 |
FDA code information
SP-623 UDI-DI 20884521037073 Lot D6A2963Y
Why was this product recalled?
Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or prolonged surgery.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Covidien LP take?
The firm began notifying consignees on 7/7/26 via email, mail, or electronically. Notices were titled, "URGENT: VOLUNTARY MEDICAL DEVICE RECALL." Customers were informed of the manufacturing nonconformance. If products in scope of this field action have been used in patients under the customer's care, the customer is instructed to monitor for signs of infection or vision issues due to the possibility of biocontamination. Customers were instructed to immediately identify, cease use, and quarantine all unused impacted product. Unused impacted product is to be returned to Medtronic. The recall notice should be passed on to all those who need to be aware within the customer's organization or to any organization where devices have been transferred.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2921-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 20, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 20, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology